![](https://www.nsmedicaldevices.com/wp-content/uploads/sites/2/2022/03/biobutton-rechargeable-press-release.jpg)
Clinical intelligence company BioIntelliSense has expanded its remote care technologies portfolio with the launch of a new rechargeable wearable monitoring device, BioButton.
The device can track patient health based on various parameters by analysing a wide range of more than 20 vital signs and physiologic biometrics for up to 30 days on a single charge.
BioButton can remotely detect a patient’s condition with the help of a set of indicators. The new addition provides a simple and economical monitoring solution for patients with a need for chronic, complex care for a long period, said BioIntelliSense.
According to the firm, the device will reduce the expense and manpower needed for the collection of routine vital signs physically.
The device when paired with FDA-cleared BioSticker medical device can provide up to 1,440 passive vital sign measurements per day in comparison to episodic manual vital sign collection at the patient bedside four to six times a day. This can help to identify the adverse trend in treatment thus giving time to correct the course of action.
BioIntelliSense founder and CEO James Mault said: “Our commitment to making remote patient care ubiquitous and scalable is further advanced with the introduction of the BioButton Rechargeable device, and accelerates remote monitoring initiatives within the hospitals, provider organisations and payors that are seeking medical-grade continuous monitoring solutions that combine an effortless user experience with clinical accuracy.
“The BioButton Rechargeable is the easy button for a healthcare workforce in crisis, realizing a new standard in remote care that is effortless for the patient and clinician while allowing providers to scale care without scaling costs.”
The device measures the vitals and sends alerts based on parameters such as temperature, resting heart rate, respiratory rate, body position, activity levels, gait analysis, infection-like symptoms and more.
The monitoring solutions offered by BioIntelliSense are used in hospitals at home, ED observation and remote monitoring at home across the US.